Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood ...

Be Biopharma has raised $92 million to support the first-in-human Phase 1/2 trial of BE-101, which is made to lower bleeding ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that ...

Countries such as China and India are expected to lead the market. The ageing population and the increasing prevalence of ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in people with hemophilia A, the ...

A recent study provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that saliva contains ...

and More Non-O blood types have 25 to 30% higher levels of blood-clotting proteins known as von Willebrand factor and factor ...

Otis has received several blood transfusions over the years at UC Davis, which is sourced by UC Davis from local volunteers.

Two hemophilia patients in the U.S. who struggled for years with bleeds have been given Hemgenix, the first gene therapy ...